Literature DB >> 8469774

Regulated expression of angiotensin II (AT2) binding sites in R3T3 cells.

D T Dudley1, R M Summerfelt.   

Abstract

R3T3 cells are a fibroblast cell line found to selectively express the AT2 subtype of angiotensin II binding sites. We have previously shown that in these cells, the AT2 sites do not appear to be coupled to G-proteins, do not modulate any of the common second messenger pathways associated with activation of angiotensin II receptors, and do not internalize bound ligand. Here we report that expression of AT2 sites in these cells are subject to modulation by a variety of conditions. In actively growing cells the expression of AT2 sites is very low, while in confluent, quiescent cells, the expression of AT2 sites is markedly increased. Addition of serum, or growth factors, to quiescent cells causes a rapid decrease in the number of cell-surface AT2 sites. Further, incubation of cells with ligands that bind to AT2 sites causes a marked increase in the number of these sites in a time and dose dependent manner indicating homologous up-regulation of expression. These results indicate that expression of AT2 sites in R3T3 cells is under sensitive and rapid control and further indicate that these cells may be an excellent model for studying the physiological regulation of expression of these sites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8469774     DOI: 10.1016/0167-0115(93)90243-2

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  12 in total

Review 1.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

2.  Agonist-dependent up-regulation of thyrotrophin-releasing hormone receptor protein.

Authors:  Laurie B Cook; Patricia M Hinkle
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

Review 3.  The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.

Authors:  Tina Thethi; Masumi Kamiyama; Hiroyuki Kobori
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 5.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

6.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Characterization of AT2 receptor expression in NIH 3T3 fibroblasts.

Authors:  F M Heemskerk; S Zorad; N Xu; S J Gutkind; J M Saavedra
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

8.  A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy.

Authors:  Takaaki Senbonmatsu; Takako Saito; Erwin J Landon; Otsu Watanabe; Edward Price; Richard L Roberts; Hans Imboden; Trinita G Fitzgerald; F Andrew Gaffney; Tadashi Inagami
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

9.  Angiotensin II type 2 receptor mediates programmed cell death.

Authors:  T Yamada; M Horiuchi; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

10.  Purification and characterization of angiotensin II AT2 receptors from neonatal rat kidney.

Authors:  G M Ciuffo; F M Heemskerk; J M Saavedra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.